Corrigendum to ‘Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis’ [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077]
Titel:
Corrigendum to ‘Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis’ [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077]
Auteur:
Pipe, Steven W. Trzaskoma, Ben Minhas, Miranda Lehle, Michaela Ko, Richard H. Gao, Ling Mahlangu, Johnny Kempton, Christine L. Kessler, Craig M. Kruse-Jarres, Rebecca
Verschenen in:
Research and practice in thrombosis and haemostasis